TytoCare Receives FDA Clearance for AI-Powered Wheeze Detection to Expand Virtual Primary Care Offerings from Home

TytoCare, a leading virtual care company that offers accessible, high-quality primary care from the comfort of your home, has announced today that it has obtained FDA clearance for its Tyto Insights™ for Wheeze Detection. This breakthrough technology enhances the company's existing AI-powered Tyto Insights™ smart diagnostic capabilities and addresses the quality gaps commonly experienced with traditional telehealth. The wheeze detection algorithm also helps alleviate the ongoing shortage of healthcare professionals.

Tyto Insights™ for Wheeze Detection is an innovative solution designed to assist in the remote clinical assessment of lung sound data for patients aged two and above. This groundbreaking technology leverages TytoCare's vast database of lung sounds, the largest of its kind, to provide clinicians with accurate diagnoses of respiratory conditions. The AI-powered decision support software automatically analyzes lung sounds recorded by TytoCare's FDA-cleared handheld remote exam device's stethoscope to detect wheezing, prompting clinicians whenever a remote lung exam is carried out.

With the FDA clearance, TytoCare further strengthens its commitment to providing the best possible virtual primary care from the comfort of your own home with its Home Smart Clinic. Tyto Insights for Wheeze Detection bolsters the Home Smart Clinic's support of acute care and long-term care for chronic conditions, many of which are respiratory in nature. To date, TytoCare has found that respiratory diagnoses constitute over 40% of all diagnoses made using its virtual care solution. This statistic reflects both the common nature of respiratory illnesses and the company's unique ability to provide optimal virtual care for large numbers of patients with respiratory symptoms by offering remote auscultation.

Dedi Gilad, CEO and Co-Founder of TytoCare, said, "Our Tyto Insight capabilities, including our wheeze detection algorithm, furthers our goal of enhancing the virtual care experience for all patients, clinicians, providers, and health plans. Our technology increases the quality of care and expands our chronic care management capabilities, further assisting clinicians and specialists in making informed and accurate diagnoses remotely. We have the world's largest database of lung and heart sounds, as well as related symptoms and vital signs, and we will continue to leverage it to provide superb quality of care for families worldwide."

The Home Smart Clinic by TytoCare addresses the Home Healthcare Delivery Gap™ that patients experience with traditional audio/video-only telehealth solutions. The solution combines TytoCare's FDA-cleared handheld remote examination device, the AI-backed Tyto Insights™ smart diagnosis support, including the Wheeze Detection, and the Tyto Engagement Labs™ configured for each specific program and cohort to provide high-quality, accessible virtual care in the home. The Tyto Insights for Wheeze Detection already bears the CE Mark for usage by clinicians in Europe.

If you want to learn more about TytoCare's innovative solutions, visit Booth #720 at ViVE 2023 in Nashville, Tennessee, from March 26-29.

Press Contacts

Allison Grey, Headline Media, prtyto[at]headline.media, +1 323 283 8176, +44 203 807 4482